ELTX icon

Elicio Therapeutics
ELTX

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$17
44% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
R&R
Rodman & Renshaw
Michael King
100% 1-yr ELTX win rate
10 Mar ‘26 yesterday